Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2476775 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL18917031 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL666140 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL30801428 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL417576 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL29388642 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL30059530 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL2477982 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL128589 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL3161061 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332080-A1 | Skin Cell Energy Booster Composition | CARBOCODE S A (PT) | 2025-10-30 | — | — | US | disclosed |
| EP-4514315-A1 | SKIN CELL ENERGY BOOSTER COMPOSITION | CARBOCODE S.A. (PT) | 2025-03-05 | — | — | EP | disclosed |
| US-20240238186-A1 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | CARBOCODE S.A. (PT) | 2024-07-18 | — | — | US | disclosed |
| EP-4329718-A1 | TOPICAL COMPOSITIONS COMPRISING (GLYCO)SPHINGOLIPIDS AND/OR (GLYCO)CERAMIDES | CARBOCODE S.A. (PT) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023209655-A1 | SKIN CELL ENERGY BOOSTER COMPOSITION | CARBOCODE S.A. (PT) | 2023-11-02 | — | — | WO | disclosed |
| WO-2022231448-A1 | TOPICAL COMPOSITIONS COMPRISING (GLYCO)SPHINGOLIPIDS AND/OR (GLYCO)CERAMIDES | CARBOCODE S.A. (PT) | 2022-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332080-A1 | Skin Cell Energy Booster Composition | LRBA, ACACB, GLB1 | NAAA 3356/4885EPHX1 1879/4885TSHR 3526/4885 |
| US-20240238186-A1 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | UGCG, CERT1, CERS2 | NAAA 2104/4885EPHX1 825/4885TSHR 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.